Dose Response of Inhaled Corticosteroids in Children With Persistent Asthma: A Systematic Review

Pediatrics, 01/18/2011

Compared with low doses, moderate doses of ICSs may not provide clinically relevant therapeutic advantage in children with mild–to–moderate persistent asthma. Additional RCTs are needed to clarify the dose–response relationship of ICSs in persistent childhood asthma.

Print Article Summary Cat 2 CME Report